Veterinary medicines European public assessment report (EPAR): Divence Tetra, bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant),bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccine, Status: Authorised

Q&A clinic on Product Management Service (PMS) Product User Interface - 6 June 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 June 2024, 15:30 (CEST) to 6 June 2024, 16:00 (CEST)

Q&A clinic on Product Management Service (PMS) Product User Interface - 27 June 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 June 2024, 15:30 (CEST) to 27 June 2024, 16:00 (CEST)

Veterinary medicines European public assessment report (EPAR): Divence Penta, Bovine respiratory syncytial virus, strain LYM-56, Live / Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live / Bovine parainfluenza virus 3, strain SF-4 Reisinger, Inactivated / Bovine viral diarrhoea virus 1, E2 recombinant protein / Bovine viral diarrhoea virus 2, E2 recombinant protein, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Enteroporc Coli, Neonatal piglet colibacillosis vaccine (recombinant, inactivated), Status: Withdrawn

Eighth Industry Standing Group (ISG) meeting, European Medicines Agency, Amsterdam, the Netherlands, 25 March 2024

User guide for micro, small and medium-sized enterprises

Veterinary medicines European public assessment report (EPAR): Meloxoral, meloxicam, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Librela, bedinvetmab, Status: Authorised

Human medicines European public assessment report (EPAR): Kinharto, Omecamtiv mecarbil, Date of refusal: 07/05/2024, Status: Withdrawn application